Kyverna Therapeutics Inc KYTX

$5.85 -0.04 (-0.68%)

Valuation

Market cap
364,255,000
Revenue TTM
$0
Net income TTM
$-161,310,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.15

Trading

Volume
847,800
Avg volume
865,090
Day's range
$5.83 – $6.12
Shares out
61,843,000
Stochastic %K
61%
Beta
2.06
Analysts
Strong Sell
Price target
$30.40

Price

Company profile

Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and autoimmune diseases. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole bl...

Show more

Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and autoimmune diseases. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.

Industry
Biotechnology
Sector
Healthcare
Phone
510 925 2492
Website
https://kyvernatx.com
Address
5980 Horton Street, Suite 550, EmeryVille, United States

Latest news

Stocktwits

keifriendly Oct 30, 2:04 PM
$CABA $KYTX buyer again below $1.39 and $5.43 respectively. Long.
0 replies
Greenenergy33 Oct 30, 1:37 PM
$KYTX loparla the newbie 🥰🥰🥰 we are green
0 replies
Roaring_Capybara Oct 30, 1:16 PM
$KYTX I'm smelling a major market correction .... If not a short-term crash...... INTC, RDDT, AMZN, SNDK. Yesterday featured NOW and GOOG.
2 replies
mike755 Oct 30, 12:13 PM
$KYTX My guess is a BO will not happen because nobody can afford the fair price for the huge potential. They may form a partnership with Gilead on either naSPMS or RA to get $250 million upfront and share revenue. This will conserve 70% of the potential for KYTX shareholders instead of a fire sale.
1 replies
xersdave Oct 30, 12:08 PM
$KYTX Bittle me this…What will the BO price be?
0 replies
Loparla Oct 30, 12:00 PM
$KYTX is today going to be a slaughter again
1 replies
shahid7777 Oct 30, 3:40 AM
$KYTX tomorrow morning looks really eventful. Hope there is a sector rotation instead of a market wide sell off 🤞
0 replies
ZackInvest008 Oct 29, 10:02 PM
$KYTX getting some borrow rate creep
1 replies